BIOMAT Database Logo BIOMAT Database Logo

[Recombinant interferons: pharmacokinetics and therapeutic implications]. 1998

S Läer
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universitäts-Krankenhaus Eppendorf, Hamburg. laeer@uke.uni-hamburg.de

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Läer
Melanoma: therapeutic options with recombinant interferons.
December 1985, Seminars in oncology,
S Läer
[Chrono-pharmacokinetics. Therapeutic implications].
January 1990, Anales de la Real Academia Nacional de Medicina,
S Läer
Recombinant human interferons.
January 1985, Arzneimittel-Forschung,
S Läer
Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.
December 1987, Clinical pharmacokinetics,
S Läer
[The pharmacokinetics of interferons].
September 1986, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
S Läer
[Pharmacokinetics of human interferons].
April 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
S Läer
Clinical pharmacokinetics of interferons.
November 1990, Clinical pharmacokinetics,
S Läer
Clinical pharmacokinetics of alprazolam. Therapeutic implications.
June 1993, Clinical pharmacokinetics,
S Läer
[Recombinant TSH and TSH analogs. Therapeutic implications?].
June 1998, Der Internist,
S Läer
[Interferons. Structure, functions and therapeutic applications of interferons].
January 1993, Annales de medecine interne,
Copied contents to your clipboard!